Search research articles
Contact Us
Filters
Showing results (131-140 of 182) with videos related to
Page
of 19
Sort By:
The British Journal of Dermatology
|
December 26, 2025
Randomized, double-blind treatment withdrawal or continuation with ruxolitinib cream in vitiligo: findings from the TRuE-V long-term extension phase 3 study
John E Harris, Kim Papp, Khaled Ezzedine, et al.
The British Journal of Dermatology
|
December 17, 2025
Open-label treatment extension of ruxolitinib cream in vitiligo: findings from the TRuE-V long-term extension phase 3 study
John E Harris, Kim Papp, Khaled Ezzedine, et al.
The Journal of Allergy and Clinical Immunology
|
September 26, 2017
Childhood chronic prurigo: Interest in patch tests and delayed-reading skin prick tests to environmental allergens
Claire Maridet, Martin Perromat, Juliette Miquel, et al.
Journal of the American Academy of Dermatology
|
August 10, 2018
Association of skin hyperpigmentation disorders with digital ulcers in systemic sclerosis: Analysis of a cohort of 239 patients
Vaianu Leroy, Pauline Henrot, Thomas Barnetche, et al.
Dermatology and Therapy
|
December 14, 2021
Unmet Educational Needs and Clinical Practice Gaps in the Management of Generalized Pustular Psoriasis: Global Perspectives from the Front Line
Bruce Strober, Joyce Leman, Maja Mockenhaupt, et al.
The Journal of Investigative Dermatology
|
January 20, 2020
Decreased CCN3 in Systemic Sclerosis Endothelial Cells Contributes to Impaired Angiogenesis
Pauline Henrot, François Moisan, Paôline Laurent, et al.
Nature Communications
|
August 26, 2024
Type I interferon signaling induces melanoma cell-intrinsic PD-1 and its inhibition antagonizes immune checkpoint blockade
Julia Holzgruber, Christina Martins, Zsofi Kulcsar, et al.
Dermatology and Therapy
|
February 5, 2026
Long-Term Safety and Efficacy of Tralokinumab in Patients with Moderate-to-Severe Atopic Dermatitis Treated for up to 6 Years: Final Results from the Open-Label Extension Trial ECZTEND
Andrew Blauvelt, H Chih-Ho Hong, Norito Katoh, et al.
Pigment Cell & Melanoma Research
|
April 6, 2017
Meeting report: Vitiligo Global Issues Consensus Conference Workshop "Outcome measurement instruments" and Vitiligo International Symposium, Rome, Nov 30-Dec 3rd
Nanja van Geel, Katia Boniface, Julien Seneschal, et al.
JCI Insight
|
December 21, 2018
OX40L/OX40 axis impairs follicular and natural Treg function in human SLE
Clément Jacquemin, Jean-François Augusto, Marc Scherlinger, et al.
Page
of 19
Search research articles
Search
Showing results (131-140 of 182) with videos related to
Sort By:
Page
of 19
The British Journal of Dermatology
|
December 26, 2025
Randomized, double-blind treatment withdrawal or continuation with ruxolitinib cream in vitiligo: findings from the TRuE-V long-term extension phase 3 study
John E Harris, Kim Papp, Khaled Ezzedine, et al.
The British Journal of Dermatology
|
December 17, 2025
Open-label treatment extension of ruxolitinib cream in vitiligo: findings from the TRuE-V long-term extension phase 3 study
John E Harris, Kim Papp, Khaled Ezzedine, et al.
The Journal of Allergy and Clinical Immunology
|
September 26, 2017
Childhood chronic prurigo: Interest in patch tests and delayed-reading skin prick tests to environmental allergens
Claire Maridet, Martin Perromat, Juliette Miquel, et al.
Journal of the American Academy of Dermatology
|
August 10, 2018
Association of skin hyperpigmentation disorders with digital ulcers in systemic sclerosis: Analysis of a cohort of 239 patients
Vaianu Leroy, Pauline Henrot, Thomas Barnetche, et al.
Dermatology and Therapy
|
December 14, 2021
Unmet Educational Needs and Clinical Practice Gaps in the Management of Generalized Pustular Psoriasis: Global Perspectives from the Front Line
Bruce Strober, Joyce Leman, Maja Mockenhaupt, et al.
The Journal of Investigative Dermatology
|
January 20, 2020
Decreased CCN3 in Systemic Sclerosis Endothelial Cells Contributes to Impaired Angiogenesis
Pauline Henrot, François Moisan, Paôline Laurent, et al.
Nature Communications
|
August 26, 2024
Type I interferon signaling induces melanoma cell-intrinsic PD-1 and its inhibition antagonizes immune checkpoint blockade
Julia Holzgruber, Christina Martins, Zsofi Kulcsar, et al.
Dermatology and Therapy
|
February 5, 2026
Long-Term Safety and Efficacy of Tralokinumab in Patients with Moderate-to-Severe Atopic Dermatitis Treated for up to 6 Years: Final Results from the Open-Label Extension Trial ECZTEND
Andrew Blauvelt, H Chih-Ho Hong, Norito Katoh, et al.
Pigment Cell & Melanoma Research
|
April 6, 2017
Meeting report: Vitiligo Global Issues Consensus Conference Workshop "Outcome measurement instruments" and Vitiligo International Symposium, Rome, Nov 30-Dec 3rd
Nanja van Geel, Katia Boniface, Julien Seneschal, et al.
JCI Insight
|
December 21, 2018
OX40L/OX40 axis impairs follicular and natural Treg function in human SLE
Clément Jacquemin, Jean-François Augusto, Marc Scherlinger, et al.
Page
of 19